PMID: 8960709Nov 1, 1996Paper

Truncated glucagon-like peptide-1 and oxyntomodulin stimulate somatostatin release from rabbit fundic D-cells in primary culture

Experimental Physiology
Ian L P Beales, John Calam

Abstract

The ability of the proglucagon-derived peptides oxyntomodulin and truncated glucagon-like peptide-1 (7-36)amide to stimulate somatostatin release from cultured rabbit fundic D-cells was assessed. Significant stimulation of somatostatin release was seen with both peptides at 10 nM. Potentiation of the stimulatory action of cholecystokinin was seen with both peptides at both 100 pM and 10 nM. The paracrine release of somatostatin from fundic D-cells may explain the acid inhibitory actions of the enteroglucagons. The different small bowel-derived peptides may interact at the level of the D-cell to regulate gastric acid secretion.

Citations

Nov 14, 2008·Current Gastroenterology Reports·Mitchell L Schubert
Jun 28, 2013·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·Efrat BroideMicha J Rapoport
Jan 21, 2003·Laboratory Investigation; a Journal of Technical Methods and Pathology·Umberto LaforenzaUlderico Ventura

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Biology of GLP-1

Glucagon-like peptide 1 (GLP-1) plays a role in glucose metabolism, energy homeostasis, and inflammation suppression. GLP-1 receptor signaling has been shown to impact cardiovascular function. This feed focuses on the role of GLP-1 and GLP-1 receptor agonists on cardiovascular biology.